Delivery Order 36F79722D0165-36C24924N0434
Award Date 4/15/24
Potential Completion Date 5/15/24
Potential Value $6K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
La Vergne, TN 37086, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm-fixed-price delivery order to Ardelyx, Inc., a for-profit pharmaceutical company, to provide the drug XPHOZAH [TENAPANOR] for the Boro VAMC Pharmacy. The contract, valued at $6,048.81, was issued under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule and has a completion date of April 2024. This delivery order was not set aside for any specific socioeconomic category. Ardelyx currently holds...
- This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Ardelyx, Inc., a for-profit pharmaceutical company, to provide the drug XPHOZAH [TENAPANOR] to VA medical centers. The firm-fixed-price delivery orders, valued at $6,048.81 each, were issued under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Ardelyx currently holds two active Indefinite Delivery Vehicles (IDVs) under the same FSS schedule, enabling the company to...
- Ardelyx, Inc., a pharmaceutical company based in Fremont, California, was awarded a delivery order for XPHOZAH 30 mg by Veterans Integrated Service Network 5 (VISN 5), a component of the Department of Veterans Affairs. This contract, valued at $2,016.52, represents a firm fixed-price delivery order issued on September 19, 2025, with an ultimate completion date of September 23, 2025. The award is performed under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and will be...
- On April 7, 2021, the Department of Veterans Affairs Veterans Integrated Service Network 6 awarded a delivery order contract to Otsuka America Pharmaceutical Inc. for medication with a ceiling value of $10,303.50. This firm fixed-price delivery order, which is not set-aside designated, is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and requires performance at the contractor's facility in Potomac, Maryland, with an ultimate completion date of April 30, 2021....
- The Department of Veterans Affairs Veterans Health Administration (VA VHA) Veterans Integrated Service Network 15 has awarded a firm fixed-price delivery order contract worth $148,302.37 to Aphena Pharma Solutions-Tennessee, LLC, a for-profit pharmaceutical manufacturer and distributor. This contract is part of the VA's Pharmaceutical Prime Vendor program, which uses multiple-award indefinite delivery/indefinite quantity contracts to efficiently supply pharmaceuticals across the VA health...
- The Department of Veterans Affairs (VA) Veterans Health Administration and Veterans Integrated Service Network 12 awarded a firm fixed price delivery order contract to Acorda Therapeutics, Inc., a biotechnology company that develops drugs to improve therapies for neurological conditions. The $485,835.00 contract is for the delivery of DALFAMPRIDINE 10MG SA, a pharmaceutical product, with a completion date of July 14, 2017. The contract was issued off of the VA's Pharmaceuticals and Drugs Federal...
- The Department of Veterans Affairs, Veterans Integrated Service Network 6, awarded a $10,303.55 firm fixed-price delivery order to Otsuka America Pharmaceutical Inc. for Jynarque 15mg/45mg medication for patient E.W. The award was issued on March 26, 2021, with an ultimate completion date of April 2, 2021. This delivery order was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and does not utilize a set-aside designation. The place of performance is Richmond,...
- Otsuka America Pharmaceutical Inc. received a $14,345.31 firm fixed price delivery order from the Department of Veterans Affairs' Veterans Integrated Service Network 6 (VISN 6) on February 10, 2021, with a completion date of February 26, 2021. The contract, which was not issued under a set-aside designation, procures Jynarque (tolvaptan), a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia. This delivery order was issued under the...
- The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a $161,106.60 delivery order contract to Actelion Pharmaceuticals US, Inc., a for-profit manufacturer of pharmaceutical products, to provide the drug Selexipag. This order is placed against Actelion's existing $105 million Federal Supply Schedule (FSS-61-IB) contract for Pharmaceuticals and Drugs and a separate $60 million Blanket Purchase Agreement focused on pulmonary arterial hypertension therapies. Actelion...
- This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Acorda Therapeutics, Inc., a biotechnology company specializing in neurological therapies. The $861,948.00 contract is for the supply of DALFAMPRIDINE, a medication used to treat Parkinson's disease symptoms. The contract is placed under Acorda's Federal Supply Schedule (FSS) contract with the VA, which is valued at over $16.3 million and allows the VA to procure Acorda's pharmaceutical...